Tocagen, a biopharmaceutical company, aims to develop cancer-selective gene therapy products to fight cancer by increasing the lifespan of patients with advanced local and metastatic cancer. Their products will activate a patient's immune system against their cancer, generating a broadly applicable cure for the disease.